IJ Radiology
Advanced quantitative information such as radiomics features derived from magnetic resonance (MR) image may be useful for outcome prediction, prognostic models or response biomarkers in Glioblastoma (GBM), knowledge about their Reproducibility and robustness is essential. The purpose of this study was to investigate the reproducible and non-redundant radiomics texture features in oncological GBM MRI based on test-retest setup.
Thirteen patients with recurrent GBM who underwent repeated MR imaging approximately two day interval were subjected to this study. Lesions were segmented using competitive region-growing based algorithm. Following delineation and segmentation of lesions, 158 quantitative 3D features based on intensity histograms (IH), gray level run-length (GLRLM), gray level co-occurrence (GLCM), gray level size-zone texture matrices (GLSZM), neighborhood-difference matrices (NDM), and geometric features were extracted from the 3D-tumor volumes of each lesion. For every radiomics feature, test-retest was assessed with the intra-class correlation coefficient (ICC) and the concordance correlation coefficient (CCC) and finally the most reproducible and robust radiomics features were selected.
Results shows that the 74% of assessed radiomics features had a high test-retest stability in terms of their ICC. There were 107 radiomics features with CCC >0.95 and 49 radiomics features were non-redundant after grouping features with R2Bet ? 0.95.
Test-retest and correlation analyses have identified non-redundant radiomics features and this feature are prone to errors if they employed as quantitative biomarker for GBM image analysis. However when we use robust and redundant feature, quantitative image radiomics features are informative and prognostic biomarkers for GBM Magnetic resonance imaging.
© 2017, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Touabti KMM, Kharfi F, Benkahila K, Merouane S. Computed Tomography/Magnetic Resonance Imaging (CT/MRI) Image Registration and Fusion Assessment for Accurate Glioblastoma Radiotherapy Treatment Planning. Int J Cancer Manag. 2020;13(9):e103160. doi: https://doi.org/10.5812/ijcm.103160
Jalab HA, Hasan AM. Magnetic Resonance Imaging Segmentation Techniques of Brain Tumors: A Review. Arch Neurosci. 2019;6(Brain Mapping):e84920. doi: https://doi.org/10.5812/ans.84920
Raminfard S, Haghighatkhah H, Alimohamadi M, Yoonessi A, Arbabi F, et al. Assessment of Residual Tumor After Resection of Glioma: A Magnetic Resonance Spectroscopic Study. Arch Neurosci. 2019;6(Brain Mapping):e88159. doi: https://doi.org/10.5812/ans.88159
Miri M, Mohseni M, Madadi A, Firouznia K, Saligheh Rad H, et al. Efficacy of 1H-MRSI and DWI for Non-invasive Grading of Brain Gliomas. I J Radiol. 2017;14(2):e17817. doi: https://doi.org/10.5812/iranjradiol.17817
Ghodsi SM, Khoshnevisan A, Arjipour M, Ghanaati H, Firouznia K, et al. Diagnostic Efficacy of Perfusion Magnetic Resonance Imaging in Supratentorial Glioma Grading. I J Radiol. 2018;15(2):e13696. doi: https://doi.org/10.5812/iranjradiol.13696
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):
